Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers from around the globe
50 sessions in 3 parallel tracks


Rheumatoid Arthritis (RA) Biomarkers

Rheumatoid arthritis (RA) is a phenotypically heterogeneous autoimmune disease causing chronic inflammation of synovial tissue. RA typically requires lifelong treatment with close monitoring of disease activity to prevent irreversible joint damage and physical disability. However, there is no precedent for biomarkers in inflammatory disease and there are currently no personalized treatments in RA. This panel of innovators in the field addresses the outstanding questions for understanding the pathobiology of RA, the work that has been accomplished toward identifying biomarkers and the areas that they are currently pursuing to fill the voids. Additionally, the currently available Vectra DA, multi-biomarker blood test that measures RA disease activity to help monitor patients during treatment and evaluate their risk for future joint damage, will be discussed.


Eric Sasso, M.D., Vice President, Medical and Scientific Affairs, Crescendo Bioscience

Dr. Sasso joined Crescendo Bioscience in September 2012. He came to Crescendo from Abbott Laboratories, where as Medical Director, he worked in Early Immunology clinical development and in Humira Medical Affairs, both in Rheumatology and as head of the Dermatology team. Read Full Bio

Michael Townsend, Ph.D., Senior Scientist, Immunology, Tissue Growth and Repair Diagnostics Discovery, Genentech

Michael Townsend Ph.D. is a Scientist in Genentech’s Research and Early Development Organization working on drug development in the Immunology space. His responsibilities include predictive biomarker discovery for both late stage research and early development programs with a primary focus on the Rheumatology area. Read Full Bio

William Robinson, M.D., Ph.D., Associate Professor, Division of Immunology and Rheumatology, Stanford University / Staff Physician, VA Palo Alto Health Care System

Dr. Robinson's research focuses on elucidation of the mechanisms underlying rheumatic diseases, including rheumatoid arthritis and osteoarthritis. The major objective of Dr. Robinson’s laboratory is translational bench-to-bedside research, with the goal of rapidly converting discoveries at the bench into practical patient care tools and therapies. Read Full Bio

Web Analytics